首页 > 最新文献

Journal of Psoriasis and Psoriatic Arthritis最新文献

英文 中文
Corrigendum to Proportions of Biologic Discontinuation Among Psoriasis Patients With Metabolic Comorbidities. 伴有代谢合并症的银屑病患者生物停药比例的勘误表
Q3 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-23 DOI: 10.1177/24755303231195867

[This corrects the article DOI: 10.1177/24755303221131257.].

[此处更正了文章 DOI:10.1177/24755303221131257]。
{"title":"Corrigendum to Proportions of Biologic Discontinuation Among Psoriasis Patients With Metabolic Comorbidities.","authors":"","doi":"10.1177/24755303231195867","DOIUrl":"10.1177/24755303231195867","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1177/24755303221131257.].</p>","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":" ","pages":"198"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48857307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to A Case of Grover's Disease Secondary to Brodalumab Therapy for Psoriasis. 更正一例Brodalumab治疗银屑病继发Grover病
Q3 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-31 DOI: 10.1177/24755303231195863

[This corrects the article DOI: 10.1177/2475530320970530.].

[此处更正了文章 DOI:10.1177/2475530320970530]。
{"title":"Corrigendum to A Case of Grover's Disease Secondary to Brodalumab Therapy for Psoriasis.","authors":"","doi":"10.1177/24755303231195863","DOIUrl":"10.1177/24755303231195863","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1177/2475530320970530.].</p>","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":" ","pages":"188"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46427826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to Likelihood of COVID-19 Vaccination Among Individuals Living With Psoriatic Disease: Results From a Large Real-World Survey. 银屑病患者接种COVID-19疫苗的可能性的勘误表:来自大型现实世界调查的结果
Q3 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-23 DOI: 10.1177/24755303231195873

[This corrects the article DOI: 10.1177/24755303211067822.].

[此处更正了文章 DOI:10.1177/24755303211067822]。
{"title":"Corrigendum to Likelihood of COVID-19 Vaccination Among Individuals Living With Psoriatic Disease: Results From a Large Real-World Survey.","authors":"","doi":"10.1177/24755303231195873","DOIUrl":"10.1177/24755303231195873","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1177/24755303211067822.].</p>","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":" ","pages":"185"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361530/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45407907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to Nail Changes in Psoriasis: Correlation Between Onychoscopy and NAPSI Scoring. 银屑病指甲变化更正:甲癣镜检查与NAPSI评分的相关性
Q3 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-31 DOI: 10.1177/24755303231195872

[This corrects the article DOI: 10.1177/24755303211011477.].

[此处更正了文章 DOI:10.1177/24755303211011477]。
{"title":"Corrigendum to Nail Changes in Psoriasis: Correlation Between Onychoscopy and NAPSI Scoring.","authors":"","doi":"10.1177/24755303231195872","DOIUrl":"10.1177/24755303231195872","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1177/24755303211011477.].</p>","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":" ","pages":"200"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46980484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Systematic Review of Follicular Psoriasis: A Unique but Under-Recognized Entity. 毛囊性银屑病的系统评价:一种独特但未被充分认识的实体
Q3 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-24 DOI: 10.1177/24755303231196567
Kelli Jablon, Jonathan D Ho, Hye Jin Chung

Background: Follicular psoriasis (FP) is a rare and under-recognized subtype of psoriasis that affects hair follicles and can be frequently misdiagnosed due to its unique presentation.

Objective: We aimed to analyze the frequently reported clinical, histological, and dermatoscopic features of FP, as well as their treatment options.

Methods: We conducted a systematic review of the PubMed/MEDLINE database using the search terms "follicular" and "psoriasis." Fourteen studies were included yielding information on 44 patients (27 adults [61.4%] and 17 children [38.6%]).

Results: Adult FP showed a female predominance (M:F = 1:2.7), frequent involvement of lower extremities (81.5%), association with metabolic syndrome including diabetes mellitus (22.2%), and a predilection for skin of color (SOC:White = 8:1). On the contrary, juvenile FP revealed male predominance (M:F = 1:0.6), frequent involvement of the trunk (41.2%), and exclusive involvement in skin of color (SOC:White = 11:0). In addition to its unique presentation, FP tends to be misdiagnosed due to its low incidence of concomitant psoriasis (31.8%), and rare personal (18.2%) or family history (6.8%) of psoriasis. Reported histopathological features include keratotic plugging, follicular parakeratosis with or without neutrophils, psoriasiform acanthosis, hypogranulosis, and neutrophilic infiltration of follicular epithelium. Dermatoscopic findings include folliculocentric lesions with normal appearing terminal hairs, perifollicular white scale, and various vascular structures.

Conclusion: Once correctly diagnosed, patients with FP showed improvement or resolution of symptoms with various combinations of topical and systemic therapies. Understanding the demographic features and clinical presentations of FP can help address under-recognition of this clinical variant of psoriasis.

毛囊性牛皮癣(FP)是一种罕见且未被充分认识的牛皮癣亚型,它影响毛囊,由于其独特的表现,经常被误诊。我们的目的是分析经常报道的FP的临床、组织学和皮肤镜特征,以及他们的治疗方案。我们对PubMed/MEDLINE数据库进行了系统的检索,检索词为“滤泡性”和“牛皮癣”。14项研究纳入了44例患者(27例成人[61.4%]和17例儿童[38.6%])的信息。成年FP以女性为主(M:F = 1:7 .7),经常累及下肢(81.5%),与代谢综合征(包括糖尿病)相关(22.2%),偏爱有色皮肤(SOC:白色= 8:1)。相反,幼年型FP表现为雄性优势(M:F = 1:6 .6),常累及躯干(41.2%),只累及有色皮肤(SOC:White = 11:0)。除了其独特的表现外,由于其伴发牛皮癣的发生率低(31.8%),以及罕见的个人(18.2%)或家族史(6.8%),FP容易被误诊。报告的组织病理学特征包括角化性堵塞,滤泡角化不全伴或不伴中性粒细胞,牛皮癣状棘层病,低颗粒病和滤泡上皮中性粒细胞浸润。皮镜检查结果包括毛囊中心病变,终末毛外观正常,毛囊周围白色鳞片和各种血管结构。一旦正确诊断,FP患者通过局部和全身治疗的各种组合表现出症状的改善或缓解。了解FP的人口学特征和临床表现可以帮助解决对这种牛皮癣临床变体的认识不足。
{"title":"A Systematic Review of Follicular Psoriasis: A Unique but Under-Recognized Entity.","authors":"Kelli Jablon, Jonathan D Ho, Hye Jin Chung","doi":"10.1177/24755303231196567","DOIUrl":"10.1177/24755303231196567","url":null,"abstract":"<p><strong>Background: </strong>Follicular psoriasis (FP) is a rare and under-recognized subtype of psoriasis that affects hair follicles and can be frequently misdiagnosed due to its unique presentation.</p><p><strong>Objective: </strong>We aimed to analyze the frequently reported clinical, histological, and dermatoscopic features of FP, as well as their treatment options.</p><p><strong>Methods: </strong>We conducted a systematic review of the PubMed/MEDLINE database using the search terms \"follicular\" and \"psoriasis.\" Fourteen studies were included yielding information on 44 patients (27 adults [61.4%] and 17 children [38.6%]).</p><p><strong>Results: </strong>Adult FP showed a female predominance (M:F = 1:2.7), frequent involvement of lower extremities (81.5%), association with metabolic syndrome including diabetes mellitus (22.2%), and a predilection for skin of color (SOC:White = 8:1). On the contrary, juvenile FP revealed male predominance (M:F = 1:0.6), frequent involvement of the trunk (41.2%), and exclusive involvement in skin of color (SOC:White = 11:0). In addition to its unique presentation, FP tends to be misdiagnosed due to its low incidence of concomitant psoriasis (31.8%), and rare personal (18.2%) or family history (6.8%) of psoriasis. Reported histopathological features include keratotic plugging, follicular parakeratosis with or without neutrophils, psoriasiform acanthosis, hypogranulosis, and neutrophilic infiltration of follicular epithelium. Dermatoscopic findings include folliculocentric lesions with normal appearing terminal hairs, perifollicular white scale, and various vascular structures.</p><p><strong>Conclusion: </strong>Once correctly diagnosed, patients with FP showed improvement or resolution of symptoms with various combinations of topical and systemic therapies. Understanding the demographic features and clinical presentations of FP can help address under-recognition of this clinical variant of psoriasis.</p>","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":" ","pages":"141-147"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46660247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation Between Insulin Resistance and Psoriatic Arthritis Disease Activity: A Cross-Sectional Study. 胰岛素抵抗与银屑病关节炎活动性的相关性研究
Q3 Medicine Pub Date : 2023-10-01 Epub Date: 2023-05-31 DOI: 10.1177/24755303231180508
Yuliasih Yuliasih, Martino Handoyo, Lita Diah Rahmawati, Sony Wibisono, Nabilatun Nisa

Objectives: Most psoriatic arthritis (PsA) research and studies focus solely on the skin and joint manifestations, but there is also an increased risk of metabolic disorders, including insulin resistance (IR). This study aims to discover the relationship between IR and disease activity (DA) in PsA and its phenotype.

Materials and methods: Patients with PsA classified using the CASPAR criteria with the disease activity was measured using the DAPSA score, and IR was identified as an elevated HOMA-IR of >2.5. The disease phenotype was determined with Moll and Wright's classification of the PsA subtype. The Pearson correlation test examined the relationship between DA and IR. The descriptive analysis was conducted to determine the relationship between the DAPSA score and HOMA-IR value in each PsA phenotype. All tests were two-tailed, analysed with GraphPad Prism 9, and a P-value of less than .05 was considered statistically significant.

Results: From thirty-one patients, there was a strong and positive relationship between DA and IR (r = .768, P = .000). We also observed variations in DAPSA score and HOMA-IR value across different phenotypes, with symmetrical polyarthritis exhibiting the highest DAPSA score (21.55 ± 3.50) and HOMA-IR value (2.913 ± .5392) despite asymmetrical oligoarthritis that being the most frequent phenotype.

Conclusion: Our study revealed a significant association between disease activity and insulin resistance in PsA patients, with the symmetrical polyarthritis phenotype demonstrating the highest levels of DAPSA score and IR value. This finding allowed rheumatologists to behold this manifestation and could improve PsA patients' long-term outlook.

目的:大多数银屑病关节炎(PsA)的研究仅集中在皮肤和关节表现上,但代谢紊乱的风险也会增加,包括胰岛素抵抗(IR)。本研究旨在发现PsA及其表型中IR与疾病活性(DA)之间的关系。材料和方法:使用疾病活动性的CASPAR标准分类的PsA患者使用DAPSA评分进行测量,IR被确定为HOMA-IR升高>2.5。根据Moll和Wright对PsA亚型的分类来确定疾病表型。Pearson相关检验检验了DA和IR之间的关系。进行描述性分析以确定每个PsA表型中DAPSA评分和HOMA-IR值之间的相关性。所有测试都是双尾的,用GraphPad Prism 9进行分析,P值小于0.05被认为具有统计学意义。结果:在31例患者中,DA和IR之间存在强烈的正相关关系(r=.768,P=.000)。我们还观察到不同表型的DAPSA评分和HOMA-IR值的变化,对称性多关节炎表现出最高的DAPSA评分(21.55±3.50)和HOMA-IR值(2.913±.5392),尽管不对称性寡关节炎是最常见的表型。结论:我们的研究揭示了PsA患者的疾病活动性与胰岛素抵抗之间的显著相关性,对称性多关节炎表型的DAPSA评分和IR值最高。这一发现使风湿病学家能够观察到这种表现,并可以改善PsA患者的长期前景。
{"title":"Correlation Between Insulin Resistance and Psoriatic Arthritis Disease Activity: A Cross-Sectional Study.","authors":"Yuliasih Yuliasih, Martino Handoyo, Lita Diah Rahmawati, Sony Wibisono, Nabilatun Nisa","doi":"10.1177/24755303231180508","DOIUrl":"10.1177/24755303231180508","url":null,"abstract":"<p><strong>Objectives: </strong>Most psoriatic arthritis (PsA) research and studies focus solely on the skin and joint manifestations, but there is also an increased risk of metabolic disorders, including insulin resistance (IR). This study aims to discover the relationship between IR and disease activity (DA) in PsA and its phenotype.</p><p><strong>Materials and methods: </strong>Patients with PsA classified using the CASPAR criteria with the disease activity was measured using the DAPSA score, and IR was identified as an elevated HOMA-IR of >2.5. The disease phenotype was determined with Moll and Wright's classification of the PsA subtype. The Pearson correlation test examined the relationship between DA and IR. The descriptive analysis was conducted to determine the relationship between the DAPSA score and HOMA-IR value in each PsA phenotype. All tests were two-tailed, analysed with GraphPad Prism 9, and a <i>P</i>-value of less than .05 was considered statistically significant.</p><p><strong>Results: </strong>From thirty-one patients, there was a strong and positive relationship between DA and IR (r = .768, <i>P</i> = .000). We also observed variations in DAPSA score and HOMA-IR value across different phenotypes, with symmetrical polyarthritis exhibiting the highest DAPSA score (21.55 ± 3.50) and HOMA-IR value (2.913 ± .5392) despite asymmetrical oligoarthritis that being the most frequent phenotype.</p><p><strong>Conclusion: </strong>Our study revealed a significant association between disease activity and insulin resistance in PsA patients, with the symmetrical polyarthritis phenotype demonstrating the highest levels of DAPSA score and IR value. This finding allowed rheumatologists to behold this manifestation and could improve PsA patients' long-term outlook.</p>","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":" ","pages":"129-133"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47232369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to Practice Patterns of Palmoplantar Pustulosis: Patient Demographics and Treatment Options. 掌跖脓疱病的实践模式的勘误表:患者人口统计和治疗方案
Q3 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-23 DOI: 10.1177/24755303231195875

[This corrects the article DOI: 10.1177/24755303221099292.].

[此处更正了文章 DOI:10.1177/24755303221099292]。
{"title":"Corrigendum to Practice Patterns of Palmoplantar Pustulosis: Patient Demographics and Treatment Options.","authors":"","doi":"10.1177/24755303231195875","DOIUrl":"10.1177/24755303231195875","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1177/24755303221099292.].</p>","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":" ","pages":"199"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361553/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48398559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to Successful Treatment of Guttate Psoriasis With Ixekizumab: A Case Series. Ixekizumab成功治疗口腔银屑病的更正:一系列病例
Q3 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-31 DOI: 10.1177/24755303231195862

[This corrects the article DOI: 10.1177/2475530320970538.].

[此处更正了文章 DOI:10.1177/2475530320970538]。
{"title":"Corrigendum to Successful Treatment of Guttate Psoriasis With Ixekizumab: A Case Series.","authors":"","doi":"10.1177/24755303231195862","DOIUrl":"10.1177/24755303231195862","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1177/2475530320970538.].</p>","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":" ","pages":"196"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47449195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center 抑郁对银屑病-银屑病关节炎联合中心银屑病关节炎结局的矛盾影响
Q3 Medicine Pub Date : 2023-06-26 DOI: 10.1177/24755303231186405
Rebecca H. Haberman, Seungha Um, Sydney Catron, Alan Chen, Eileen Lydon, Malavikalakshmi Attur, Andrea L. Neimann, Soumya Reddy, Andrea Troxel, Samrachana Adhikari, Jose U. Scher
Backgroud Psoriatic arthritis (PsA) is a chronic, inflammatory arthritis that, when left untreated, can lead to erosions, deformities and decrease in quality of life. PsA is known to be associated with multiple comorbidities, including cardiovascular, metabolic and mental health syndromes, all of which can increase its overall morbidity and mortality. Objective To characterize a cohort of patients with PsA and understand the impact of depression on PsA outcome measures. Methods 527 consecutive patients with PsA were enrolled in an observational, longitudinal registry that followed them prospectively at standard of care visits. Demographics, medical history, medication use, and clinical exam were all recorded. Results Depression was reported in 22.8% of the population, anxiety in 18%, and attention deficit hyperactivity disorder in 4%. Depression was more common in female participants (P < .001). At baseline, individuals with PsA and concomitant depression had similar tender and swollen joint counts and RAPID3 compared to those without depression, and had lower body surface area affected by psoriasis (P = .04). At year one, all patients had improvement in clinical outcomes. However, patients with depression had a significantly higher tender joint count compared to those without depression (P = .001), despite similar swollen joint count and body surface area. Conclusion In patients with depression, there is a discrepancy between improvement in physician assessed measures and patient reported outcomes. These observations underscore the importance of addressing depression and psychological distress as part of PsA treatment outcomes and points towards the need to address residual pain through co-adjuvant approaches.
银屑病关节炎(PsA)是一种慢性炎症性关节炎,如果不及时治疗,会导致糜烂、畸形和生活质量下降。已知PsA与多种合并症有关,包括心血管、代谢和精神健康综合征,所有这些都可能增加其总体发病率和死亡率。目的研究一组PsA患者的特征,了解抑郁对PsA预后指标的影响。方法527例连续PsA患者纳入观察性纵向登记,在标准护理就诊时前瞻性随访。人口统计、病史、用药情况、临床检查均有记录。结果抑郁症占22.8%,焦虑症占18%,注意缺陷多动障碍占4%。抑郁症在女性参与者中更为常见(P <措施)。在基线时,与没有抑郁症的个体相比,患有PsA并伴有抑郁症的个体具有相似的关节压痛和肿胀计数和RAPID3,并且下体表面积受牛皮癣影响(P = 0.04)。在第一年,所有患者的临床结果都有所改善。然而,尽管肿胀的关节数和体表面积相似,抑郁症患者的柔软关节数明显高于无抑郁症患者(P = 0.001)。结论在抑郁症患者中,医生评估措施的改善与患者报告的结果存在差异。这些观察结果强调了将抑郁和心理困扰作为PsA治疗结果的一部分的重要性,并指出需要通过辅助治疗方法来解决残留疼痛。
{"title":"Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center","authors":"Rebecca H. Haberman, Seungha Um, Sydney Catron, Alan Chen, Eileen Lydon, Malavikalakshmi Attur, Andrea L. Neimann, Soumya Reddy, Andrea Troxel, Samrachana Adhikari, Jose U. Scher","doi":"10.1177/24755303231186405","DOIUrl":"https://doi.org/10.1177/24755303231186405","url":null,"abstract":"Backgroud Psoriatic arthritis (PsA) is a chronic, inflammatory arthritis that, when left untreated, can lead to erosions, deformities and decrease in quality of life. PsA is known to be associated with multiple comorbidities, including cardiovascular, metabolic and mental health syndromes, all of which can increase its overall morbidity and mortality. Objective To characterize a cohort of patients with PsA and understand the impact of depression on PsA outcome measures. Methods 527 consecutive patients with PsA were enrolled in an observational, longitudinal registry that followed them prospectively at standard of care visits. Demographics, medical history, medication use, and clinical exam were all recorded. Results Depression was reported in 22.8% of the population, anxiety in 18%, and attention deficit hyperactivity disorder in 4%. Depression was more common in female participants (P < .001). At baseline, individuals with PsA and concomitant depression had similar tender and swollen joint counts and RAPID3 compared to those without depression, and had lower body surface area affected by psoriasis (P = .04). At year one, all patients had improvement in clinical outcomes. However, patients with depression had a significantly higher tender joint count compared to those without depression (P = .001), despite similar swollen joint count and body surface area. Conclusion In patients with depression, there is a discrepancy between improvement in physician assessed measures and patient reported outcomes. These observations underscore the importance of addressing depression and psychological distress as part of PsA treatment outcomes and points towards the need to address residual pain through co-adjuvant approaches.","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135608493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to improve people-centred healthcare in dermatology? 如何改善皮肤科以人为本的医疗保健?
Q3 Medicine Pub Date : 2023-06-20 DOI: 10.55788/27076e04
R. Sommer, M. Augustin
People with chronic skin diseases, such as psoriasis, experience multifaceted impairments that include physical symptoms, such as pain, psychological symptoms, such as anxiety, and social impairments, such as stigmatisation. To address this broad spectrum of impairments, a holistic healthcare approach is needed. The World Health Organization has established the people-centred model of care, in which health services adopt the perspective of people affected and their environment. The needs of patients are respected, and patients are put at the centre of care. This model was also adopted by the global report on psoriasis, which aims to improve the wellbeing of the affected people. This paper gives a brief overview of the status quo and an outline of how to improve people-centred care and patient orientation in dermatology, specifically for people with psoriasis. This includes the application of shared decision-making. Although only a few patient decision aids for psoriasis have been published, promising results regarding the reimbursement of shared decision-making applications in the hospital setting by health insurances are available, which also refer to dermatology departments. In addition, the use of patient-reported outcomes is of great importance to give patients a voice in their own healthcare. In accordance with the people-centred model, it is recommended to not only assess patients' perspectives, such as their needs, goals, and treatment benefits, but also the needs and treatment benefits of the patients' environment, such as their partner and treating healthcare professionals. One recent example of such a people-centred approach is the POSITIVE-study, which is the first study assessing the treatment effect on the wellbeing of patients with psoriasis. Moreover, the treatment benefit on physicians' satisfaction and patients' partners' lives is being evaluated. Therefore, it could act as a best practice example of how to integrate a people-centred approach in research.
患有牛皮癣等慢性皮肤病的人会遭受多方面的损害,包括身体症状,如疼痛,心理症状,如焦虑,以及社会障碍,如污名化。为了解决这种广泛的缺陷,需要一种全面的医疗保健方法。世界卫生组织建立了以人为中心的护理模式,在这种模式中,保健服务采用受影响的人及其环境的观点。尊重病人的需要,把病人放在护理的中心。全球牛皮癣报告也采用了这一模式,该报告旨在改善受影响人群的福祉。本文简要概述了现状,并概述了如何提高以人为本的护理和患者取向在皮肤科,特别是银屑病患者。这包括共同决策的应用。虽然只有少数针对牛皮癣的患者决策辅助工具已经发表,但在医院环境中由健康保险报销共享决策应用方面,有希望的结果是可用的,这也涉及皮肤科。此外,使用患者报告的结果对于让患者在自己的医疗保健中发表意见非常重要。根据以人为中心的模式,建议不仅要评估患者的观点,如他们的需求、目标和治疗效益,还要评估患者环境的需求和治疗效益,如他们的伴侣和治疗保健专业人员。这种以人为本的方法最近的一个例子是POSITIVE-study,这是第一个评估治疗对牛皮癣患者健康影响的研究。此外,还评估了治疗对医生满意度和患者伴侣生活的益处。因此,它可以作为如何在研究中整合以人为本的方法的最佳实践范例。
{"title":"How to improve people-centred healthcare in dermatology?","authors":"R. Sommer, M. Augustin","doi":"10.55788/27076e04","DOIUrl":"https://doi.org/10.55788/27076e04","url":null,"abstract":"People with chronic skin diseases, such as psoriasis, experience multifaceted impairments that include physical symptoms, such as pain, psychological symptoms, such as anxiety, and social impairments, such as stigmatisation. To address this broad spectrum of impairments, a holistic healthcare approach is needed. The World Health Organization has established the people-centred model of care, in which health services adopt the perspective of people affected and their environment. The needs of patients are respected, and patients are put at the centre of care. This model was also adopted by the global report on psoriasis, which aims to improve the wellbeing of the affected people. This paper gives a brief overview of the status quo and an outline of how to improve people-centred care and patient orientation in dermatology, specifically for people with psoriasis. This includes the application of shared decision-making. Although only a few patient decision aids for psoriasis have been published, promising results regarding the reimbursement of shared decision-making applications in the hospital setting by health insurances are available, which also refer to dermatology departments. In addition, the use of patient-reported outcomes is of great importance to give patients a voice in their own healthcare. In accordance with the people-centred model, it is recommended to not only assess patients' perspectives, such as their needs, goals, and treatment benefits, but also the needs and treatment benefits of the patients' environment, such as their partner and treating healthcare professionals. One recent example of such a people-centred approach is the POSITIVE-study, which is the first study assessing the treatment effect on the wellbeing of patients with psoriasis. Moreover, the treatment benefit on physicians' satisfaction and patients' partners' lives is being evaluated. Therefore, it could act as a best practice example of how to integrate a people-centred approach in research.","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":"68 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75103410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Psoriasis and Psoriatic Arthritis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1